ClinicalTrials.gg
RecruitingNCT07216027Updated Nov 5, 2026

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

A Phase 2 interventional study of PF-08049820 and Placebo in Atopic Dermatitis and Eczema, Atopic, sponsored by Pfizer. Recruiting at 52 sites in 9 countries. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Pfizer · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.
Updated Nov 5, 2026First sites in 5 new countriesSite recruiting status changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
165
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 58 studies in Dermatitis, Atopic by Pfizer — 11 open to participants now, 13 under way, 4 of them phase 3. Dermatitis, Atopic · Pfizer.

Planned enrollment
21st of 47
165 · median 121
Started
2025
with 4 others
Phase 2
13 of 58
1 open now
Primary completion
2028-02
later than 7 of 12 live
Registered
53rd of 58
by date

Among the 58 studies in Dermatitis, Atopic by Pfizer, this one is the 21st largest by planned enrollment of the 47 interventional ones that give a count, is one of 5 that started in 2025, is one of 13 in phase 2, reaches primary completion later than 7 of the 12 other live ones, and was the 53rd registered.

Dermatitis, Atopic

1,594 studies on the registry are indexed under Dermatitis, Atopic; 287 are open to participants now.

Browse Dermatitis, Atopic studies →

Open to participants now

11 of the 58 studies in Dermatitis, Atopic by Pfizer are open now, in 12 countries. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Who these studies take

Of the 194 Dermatitis, Atopic studies recruiting now, 83 (43%) set no upper age limit and 95 (49%) stop at 75 or younger; 94 take children under 18; 51 take healthy volunteers.

This study: 18 Years to 64 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 58 studies in Dermatitis, Atopic by Pfizer, or all of them as a file.
02

Study summary

The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin.

The study is seeking participants who:

  1. Are 18 to 64 years of age;
  2. Were confirmed to have AD at least 6 months ago;
  3. Do not have a suitable prescribed medicine for AD;
  4. Are considered by their doctors to have moderate to severe AD.

The study has two stages (Stage 1 and Stage 2). In both stages, eligible participants will take either PF-08049820 or placebo as tablets by mouth daily for 12 weeks. A placebo does not have any medicine in it but looks just like the medicine being studied. Participants will visit the clinic on Day 1, Weeks 1, 2, 4, 6, 8 and 12. They will have a follow-up visit at Week 16. During this time, the participant's health and skin condition will be checked. They will have blood and urine tests. They will also have to answer questions about their health, skin condition, and how much their skin condition affects their lives. The experiences of participants receiving the study medicine will be compared to those receiving placebo. This will help to understand if PF-08049820 is safe and effective.

03

Conditions studied

  • Atopic Dermatitis
  • Eczema, Atopic

Keywords

  • Eczema
  • Atopic Dermatitis
04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants must meet the following criteria:

  1. Are 18 to 64 years of age
  2. Have clinical diagnosis of AD for at least 6 months prior to Day 1 and have diagnosis of AD confirmed by photographs
  3. Have moderate to severe AD as defined by the following at screening and baseline visits:

    • Affected body surface area (BSA) greater than or equal to 10% and up to 60%;
    • Validated Investigator's Global Assessment (vIGA) greater than or equal to 3;
    • Eczema Area and Severity Index (EASI) greater than or equal to 16;

    AND

    -Peak Pruritis Numeric Rating Scale (PP-NRS) greater than or equal to 4 at screening and a weekly average of greater than or equal to 4 at baseline visit

  4. Do not have a suitable prescribed medicine for AD.
  5. (BMI) of 18 to 38 kg/m2 and a total body weight greater than 48 kg (106 lbs)

Exclusion criteria

Exclusion Criteria:

Participants must not meet the following criteria:

  1. Have an infection that requires treatment
  2. Have other skin conditions other than AD
  3. Have severe uncontrolled asthma
  4. Regular use (more than 2 visits per week) of a tanning booth or phototherapy for AD within 4 weeks of the screening visit
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
165 participants (estimated)

Study arms

  • Experimental
    Arm 2

    Stages 1 and 2: Tablets taken by mouth daily for 12 weeks

    Drug: PF-08049820

  • Experimental
    Arm 3

    Stages 1 and 2: Tablets taken by mouth daily for 12 weeks

    Drug: PF-08049820

  • Experimental
    Arm 1

    Stages 1 and 2: Tablets taken by mouth daily for 12 weeks

    Drug: PF-08049820

  • Placebo comparator
    Arm 4

    Stages 1 and 2: Tablets taken by mouth daily for 12 weeks

    Drug: Placebo

Interventions

06

What researchers measure

Primary outcomes

  1. Percent change from baseline in Eczema Area and Severity Index (EASI) total score at Week 12

    Time frame: Week 12

Secondary outcomes

  1. Response based on achieving EASI75 (≥75% improvement from baseline) at scheduled time points

    Time frame: Day 1 through Week 16

  2. Percent change from baseline in EASI total score at scheduled time points other than Week 12

    Time frame: Day 1 through Week 16

  3. Response based on achieving Validated Investigator's Global Assessment (vIGA) score of clear (0) or almost clear (1) (on a 5-point scale) and a reduction from baseline of >2 points at scheduled time points

    Time frame: Day 1 through Week 16

  4. Response based on achieving ≥4 points of reduction from baseline in weekly averages of Peak Pruritus-Numerical Rating Scale (PP-NRS4) at scheduled time points

    Time frame: Day 1 through Week 16

  5. Incidence of treatment emergent adverse events (AEs) and serious adverse events (SAEs), and clinically significant changes in laboratory tests, vital signs and ECGs

    Time frame: Day 1 through Week 16

  6. Change from baseline in biomarker at scheduled time points

    Time frame: Day 1 through Week 16

07

Study locations

41 of 52 sites recruiting
  • Mayo Clinic Hospital
    Phoenix, Arizona 85054, United States
    Recruiting
  • Mayo Clinic Specialty Building
    Phoenix, Arizona 85054, United States
    Recruiting
  • Mayo Clinic
    Scottsdale, Arizona 85259, United States
    Recruiting
  • Marvel Clinical Research
    Huntington Beach, California 92647, United States
    Recruiting
  • Metropolis Dermatology - DTLA
    Los Angeles, California 90017, United States
    Not yet recruiting
  • Northridge Clinical Trials
    Northridge, California 91325, United States
    Recruiting
  • Clinical Science Institute
    Santa Monica, California 90403, United States
    Recruiting
  • Gsi Clinical Research
    Margate, Florida 33063, United States
    Recruiting
  • Skin Research of South Florida
    Miami, Florida 33173, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Montefiore - Jacobi Dermatology Clinic
    The Bronx, New York 10461, United States
    Recruiting
  • Montefiore - Clinical Research Center
    The Bronx, New York 10467, United States
    Recruiting
  • Montefiore - Greene Medical Arts Pavillion
    The Bronx, New York 10467, United States
    Recruiting
  • Montefiore - The Dermatology Center
    The Bronx, New York 10467, United States
    Recruiting
  • Montefiore Medical Center
    The Bronx, New York 10467, United States
    Recruiting
  • Apex Clinical Research Center, LLC. - Lorain
    Lorain, Ohio 44053, United States
    Recruiting
  • Apex Clinical Research Center, LLC.
    Mayfield Heights, Ohio 44124, United States
    Recruiting
  • Paddington Testing Co, Inc
    Philadelphia, Pennsylvania 19103, United States
    Recruiting
  • UPMC Department of Dermatology
    Pittsburgh, Pennsylvania 15213, United States
    Recruiting
  • ASMC - IPSMC - skin and venereal diseases
    Sofia, Sofia (stolitsa) 1407, Bulgaria
    Not yet recruiting
  • Diagnostic Consultative Centre (DCC) - Foкus 5
    Sofia, Sofia (stolitsa) 1463, Bulgaria
    Not yet recruiting
  • Diagnostic Consultative Center "Ascendent"
    Sofia, 1202, Bulgaria
    Not yet recruiting
  • Dermatology Research Institute
    Calgary, Alberta T2J 7E1, Canada
    Recruiting
  • Toronto Research Centre
    Toronto, Ontario M3H 5Y8, Canada
    Recruiting
  • Centre de Recherche Saint-Louis inc.
    Québec, G1W 4R4, Canada
    Recruiting
  • The First Affiliated Hospital of Fujian Medical University
    Fuzhou, Fujian 350005, China
    Recruiting
  • The First Affiliated Hospital of Fujian Medical University
    Fuzhou, Fujian 350008, China
    Recruiting
  • Guangdong Province Dermatology Hospital
    Guangzhou, Guangdong 510091, China
    Recruiting
  • Huashan Hospital, Fudan University
    Shanghai, Shanghai Municipality 200040, China
    Recruiting
  • Peking University People's Hospital
    Beijing, 100044, China
    Recruiting
  • DERMAMEDICA s.r.o.
    Náchod, 547 01, Czechia
    Recruiting
  • CCR Ostrava, s.r.o.
    Ostrava, 702 00, Czechia
    Recruiting
  • Pratia Czech s.r.o.
    Pardubice, 530 02, Czechia
    Recruiting
  • Pratia Czech s.r.o.
    Prague, 130 00, Czechia
    Recruiting
  • Hopital Saint Louis
    Paris, 75010, France
    Not yet recruiting
  • Hopital Charles Nicolle
    Rouen, 76031, France
    Recruiting
  • Hopital Larrey
    Toulouse, 31059, France
    Not yet recruiting
  • Universitätsklinikum Münster
    Münster, North Rhine-Westphalia 48149, Germany
    Not yet recruiting
  • Universitätsklinikum Schleswig-Holstein
    Lübeck, Schleswig-Holstein 23538, Germany
    Not yet recruiting
  • University Hospital Schleswig-Holstein
    Kiel, 24105, Germany
    Not yet recruiting
  • Hattori Dermatology Clinic
    Takasaki, Gunma 370-0071, Japan
    Recruiting
  • Kosugi Dermatology Clinic
    Kawasaki-shi, Kanagawa 211-0063, Japan
    Recruiting
  • Queen's square Medical Facilities Queen's square Dermatology and Allergology
    Yokohama, Kanagawa 220-6208, Japan
    Recruiting
  • Dermatology and Ophthalmology Kume Clinic
    Sakai, Osaka 593-8324, Japan
    Recruiting
  • Nihonbashi Sakura Clinic
    Chuo-ku, Tokyo 103-0025, Japan
    Recruiting
  • Fukuwa Clinic
    Chuo-ku, Tokyo 104-0031, Japan
    Recruiting
  • Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o.
    Krakow, Lesser Poland Voivodeship 30-348, Poland
    Recruiting
  • Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki
    Szczecin, West Pomeranian Voivodeship 70-332, Poland
    Recruiting
  • Penta Hospitals Badania Kliniczne- Gdańsk 1
    Gdansk, 80-546, Poland
    Recruiting
  • Centrum Medyczne Angelius Provita
    Katowice, 40-611, Poland
    Recruiting
  • Dermedic Jacek Zdybski
    Kielce, 25-553, Poland
    Not yet recruiting
  • Centrum Nowoczesnych Terapii Dobry Lekarz spółka z ograniczoną odpowiedzialnością
    Krakow, 31-011, Poland
    Recruiting
  • Twoja Przychodnia - Szczecinskie Centrum Medyczne
    Szczecin, 71-500, Poland
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.

Data sharing details ↗ · www.pfizer.com

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Feb 2028, 26 months after the start.

Of 196 industry-sponsored phase 2 interventional studies under Dermatitis, Atopic, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 17. This study's planned 26 months is above that.

Counting every sponsor, half of 224 studies reached it within 14 months; a quarter within 10 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2025
First posted
Oct 14, 2025
StartActual
Nov 20, 2025
Primary completionEst.
Feb 2, 2028
CompletionEst.
Feb 2, 2028
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
30 sites added, 1 site removed — first sites in Czechia, France, Poland, Bulgaria and Germany. 17 sites changed recruiting status (17 now recruiting)
Show 17 sites
  • Clinical Science Institute · Santa Monica, United StatesActive, not recruiting→Recruiting
  • Peking University People's Hospital · Beijing, ChinaNot yet recruiting→Recruiting
  • Mayo Clinic Hospital · Phoenix, United StatesNot yet recruiting→Recruiting
  • Mayo Clinic Specialty Building · Phoenix, United StatesNot yet recruiting→Recruiting
  • Mayo Clinic · Scottsdale, United StatesNot yet recruiting→Recruiting
  • CCR Ostrava, s.r.o. · Ostrava, CzechiaNot yet recruiting→Recruiting
  • Pratia Czech s.r.o. · Pardubice, CzechiaNot yet recruiting→Recruiting
  • Hopital Charles Nicolle · Rouen, FranceNot yet recruiting→Recruiting
  • Apex Clinical Research Center, LLC. · Mayfield Heights, United StatesNot yet recruiting→Recruiting
  • Toronto Research Centre · Toronto, CanadaNot yet recruiting→Recruiting
  • DERMAMEDICA s.r.o. · Náchod, CzechiaNot yet recruiting→Recruiting
  • Pratia Czech s.r.o. · Prague, CzechiaNot yet recruiting→Recruiting
  • Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o. · Krakow, PolandNot yet recruiting→Recruiting
  • Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki · Szczecin, PolandNot yet recruiting→Recruiting
  • Centrum Medyczne Angelius Provita · Katowice, PolandNot yet recruiting→Recruiting
  • Centrum Nowoczesnych Terapii Dobry Lekarz spółka z ograniczoną odpowiedzialnością · Krakow, PolandNot yet recruiting→Recruiting
  • Twoja Przychodnia - Szczecinskie Centrum Medyczne · Szczecin, PolandNot yet recruiting→Recruiting
Show 30 added (7 Poland, 5 United States, 4 Czechia, 3 France, 3 Bulgaria, 3 China, 3 Germany, 2 Canada)
  • Mayo Clinic Hospital · Phoenix, United States
  • Mayo Clinic Specialty Building · Phoenix, United States
  • Mayo Clinic · Scottsdale, United States
  • Apex Clinical Research Center, LLC. · Mayfield Heights, United States
  • Toronto Research Centre · Toronto, Canada
  • CCR Ostrava, s.r.o. · Ostrava, Czechia
  • Pratia Czech s.r.o. · Pardubice, Czechia
  • Hopital Charles Nicolle · Rouen, France
  • Hopital Larrey · Toulouse, France
  • Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o. · Krakow, Poland
  • Twoja Przychodnia - Szczecinskie Centrum Medyczne · Szczecin, Poland
  • ASMC - IPSMC - skin and venereal diseases · Sofia, Bulgaria
  • The First Affiliated Hospital of Fujian Medical University · Fuzhou, China
  • The First Affiliated Hospital of Fujian Medical University · Fuzhou, China
  • DERMAMEDICA s.r.o. · Náchod, Czechia
  • Pratia Czech s.r.o. · Prague, Czechia
  • Hopital Saint Louis · Paris, France
  • Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki · Szczecin, Poland
  • Centrum Medyczne Angelius Provita · Katowice, Poland
  • Centrum Nowoczesnych Terapii Dobry Lekarz spółka z ograniczoną odpowiedzialnością · Krakow, Poland
  • Apex Clinical Research Center, LLC. - Lorain · Lorain, United States
  • Diagnostic Consultative Centre (DCC) - Foкus 5 · Sofia, Bulgaria
  • Diagnostic Consultative Center "Ascendent" · Sofia, Bulgaria
  • Dermatology Research Institute · Calgary, Canada
  • Guangdong Province Dermatology Hospital · Guangzhou, China
  • Universitätsklinikum Münster · Münster, Germany
  • Universitätsklinikum Schleswig-Holstein · Lübeck, Germany
  • University Hospital Schleswig-Holstein · Kiel, Germany
  • Penta Hospitals Badania Kliniczne- Gdańsk 1 · Gdansk, Poland
  • Dermedic Jacek Zdybski · Kielce, Poland
Show 1 removed
  • Mayo Clinic in Arizona - Scottsdale · Scottsdale, United States
across 3 updates, Sep 25, 2026 – Nov 5, 2026
Show all 3 updates
  1. Nov 5, 2026
    10 sites added — first site in Germany. 9 sites changed recruiting status (9 now recruiting)
    Show 9 sites
    • Apex Clinical Research Center, LLC. · Mayfield Heights, United StatesNot yet recruiting→Recruiting
    • Toronto Research Centre · Toronto, CanadaNot yet recruiting→Recruiting
    • DERMAMEDICA s.r.o. · Náchod, CzechiaNot yet recruiting→Recruiting
    • Pratia Czech s.r.o. · Prague, CzechiaNot yet recruiting→Recruiting
    • Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o. · Krakow, PolandNot yet recruiting→Recruiting
    • Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki · Szczecin, PolandNot yet recruiting→Recruiting
    • Centrum Medyczne Angelius Provita · Katowice, PolandNot yet recruiting→Recruiting
    • Centrum Nowoczesnych Terapii Dobry Lekarz spółka z ograniczoną odpowiedzialnością · Krakow, PolandNot yet recruiting→Recruiting
    • Twoja Przychodnia - Szczecinskie Centrum Medyczne · Szczecin, PolandNot yet recruiting→Recruiting
    Show 10 added (3 Germany, 2 Bulgaria, 2 Poland, 1 United States, 1 Canada, 1 China)
    • Apex Clinical Research Center, LLC. - Lorain · Lorain, United States
    • Diagnostic Consultative Centre (DCC) - Foкus 5 · Sofia, Bulgaria
    • Diagnostic Consultative Center "Ascendent" · Sofia, Bulgaria
    • Dermatology Research Institute · Calgary, Canada
    • Guangdong Province Dermatology Hospital · Guangzhou, China
    • Universitätsklinikum Münster · Münster, Germany
    • Universitätsklinikum Schleswig-Holstein · Lübeck, Germany
    • University Hospital Schleswig-Holstein · Kiel, Germany
    • Penta Hospitals Badania Kliniczne- Gdańsk 1 · Gdansk, Poland
    • Dermedic Jacek Zdybski · Kielce, Poland
    + 1 other change: verification date
  2. Oct 13, 2026
    9 sites added — first site in Bulgaria. 6 sites changed recruiting status (6 now recruiting)
    Show 6 sites
    • Mayo Clinic Hospital · Phoenix, United StatesNot yet recruiting→Recruiting
    • Mayo Clinic Specialty Building · Phoenix, United StatesNot yet recruiting→Recruiting
    • Mayo Clinic · Scottsdale, United StatesNot yet recruiting→Recruiting
    • CCR Ostrava, s.r.o. · Ostrava, CzechiaNot yet recruiting→Recruiting
    • Pratia Czech s.r.o. · Pardubice, CzechiaNot yet recruiting→Recruiting
    • Hopital Charles Nicolle · Rouen, FranceNot yet recruiting→Recruiting
    Show 9 added (3 Poland, 2 China, 2 Czechia, 1 Bulgaria, 1 France)
    • ASMC - IPSMC - skin and venereal diseases · Sofia, Bulgaria
    • The First Affiliated Hospital of Fujian Medical University · Fuzhou, China
    • The First Affiliated Hospital of Fujian Medical University · Fuzhou, China
    • DERMAMEDICA s.r.o. · Náchod, Czechia
    • Pratia Czech s.r.o. · Prague, Czechia
    • Hopital Saint Louis · Paris, France
    • Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki · Szczecin, Poland
    • Centrum Medyczne Angelius Provita · Katowice, Poland
    • Centrum Nowoczesnych Terapii Dobry Lekarz spółka z ograniczoną odpowiedzialnością · Krakow, Poland
    + 1 other change: verification date
  3. Sep 25, 2026
    11 sites added, 1 site removed — first sites in Czechia, France and Poland. 2 sites changed recruiting status (2 now recruiting)
    Show 2 sites
    • Clinical Science Institute · Santa Monica, United StatesActive, not recruiting→Recruiting
    • Peking University People's Hospital · Beijing, ChinaNot yet recruiting→Recruiting
    Show 11 added (4 United States, 2 Czechia, 2 France, 2 Poland, 1 Canada)
    • Mayo Clinic Hospital · Phoenix, United States
    • Mayo Clinic Specialty Building · Phoenix, United States
    • Mayo Clinic · Scottsdale, United States
    • Apex Clinical Research Center, LLC. · Mayfield Heights, United States
    • Toronto Research Centre · Toronto, Canada
    • CCR Ostrava, s.r.o. · Ostrava, Czechia
    • Pratia Czech s.r.o. · Pardubice, Czechia
    • Hopital Charles Nicolle · Rouen, France
    • Hopital Larrey · Toulouse, France
    • Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o. · Krakow, Poland
    • Twoja Przychodnia - Szczecinskie Centrum Medyczne · Szczecin, Poland
    Show 1 removed
    • Mayo Clinic in Arizona - Scottsdale · Scottsdale, United States

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07216027
Lead sponsor
Pfizer
Responsible party
Sponsor
First posted
Oct 14, 2025
Start date
Nov 20, 2025
Primary completion
Feb 2, 2028 (estimated)
Completion
Feb 2, 2028 (estimated)
Last update
Nov 5, 2026

Study contacts

Pfizer CT.gov Call Center
Contact
ClinicalTrials.gov_Inquiries@pfizer.com
1-800-718-1021
Pfizer CT.gov Call Center
study director · Pfizer

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: PF-08049820

Start the discussion